Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine

// Kelli L. Goss 1 , Stacia L. Koppenhafer 1 , Kathryn M. Harmoney 1 , William W. Terry 1 and David J. Gordon 1 1 Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, Iowa 52242, USA Correspondence to: David J. Gordon, email: david-j-gordon@uiowa.edu Keywords: Ewing sarcoma, ribonucleotide reductase, gemcitabine, CHK1, replication stress Received: March 06, 2017     Accepted: May...